2015•American Review of Respiratory DiseaseRequires access
Severe Respiratory Depression Following Talwin
Stanley Reichenberg, Frederick Pobirs
Open publisher page 1 citations
Abstract
Severe respiratory depression occurred in a 41-year-old woman with underlying respiratory insufficiency, after she received 30 mg of pentazocine (Talwin®) intramuscularly. This drug can cause significant respiratory depression and should be used with the same precautions as narcotics in patients with limited respiratory reserve.